How a state-of-the-art MES saves time & effort and avoids risk in your pharma factory
Learn more about how to improve efficiency and compliance in your pharma or biotech factory:
Paper-based manufacturing processes in pharma or biotech are slow, error-prone and costly. On average 20% of batch deviations are caused by human error!
An MES helps you to avoid these shortcomings. It guides your operators through the production process and controls every step. QA reviews batch records in a matter of minutes instead of hours!
ケーススタディ：
PAS-X KPIは総合設備効率(OEE)の改善手法としてリーンシックスシグマを用いて大手製薬会社をサポートしています
世界的大手製薬会社が、世界中のネットワークにリーンシックスシグマを導入しました。イニシアチブの一環として、運用チームはプラント全体でOEEの改善を把握し、それを推進していくことに焦点を合わせました。同社は、既存のPAS-X MESへのシームレスな接続を提供するWerumのPAS-X KPIソリューションの使用を決定しました。すべてのバッチデータはPAS-Xから自動的に取得されるため、オペレーターからの最小限の入力で正確なKPI測定が行われます。製薬会社は、作業効率の改善および製造現場の可視性による恩恵を受けます。
今後のイベント
| Date/Location | Fair |
|---|---|
|
24 Oct - 25 Oct 2019 Lüneburg, Germany |
European PAS-X User Group Meeting 2019 |
|
05 Nov - 07 Nov 2019 Wuhan International Exposition Center, China |
China International Pharmaceutical Machinery Exposition, booth #S1-04 |
|
05 Nov - 07 Nov 2019 Frankfurt, Germany |
CPhI Worldwide, hall 11.0, booth #G13 |
|
06 Nov - 07 Nov 2019 Singapore |
Cell & Gene Therapy APAC 2019 (co-located with The 5th Annual Biopharma Development & Production Asia Pacific Conference) |
|
12 Nov - 13 Nov 2019 Berlin, Germany |
7th Serialization Symposium |
ファーマ4.0の強化
システム、装置及び人材はデジタル化された経済社会においてますます相互接続され、製薬およびバイオテクノロジー業界に新たな機会を提供しています。我々の関連会社であるMedipak Systems社や他のパートナーと共に、Werum IT Solutionsはインダストリー4.0を製薬業界で実現する革新的なソリューションに取り組んでいます。
PAS-X Newsletter
Cloud-based MES, innovative control concepts, EMI, Pharma 4.0, new reference projects, Self-Service Portal, cell therapy, data integrity
In our Newsletter we show you, how we have brought three game-changing ideas into reality: PAS-X as a Service – our market-leading MES in the cloud, innovative operating concepts – AR, wearables and voice-directed technology, and our new Enterprise Manufacturing Intelligence solutions. Learn more about how we apply Industrie 4.0 technologies to pharma manufacturing and which Pharma 4.0 solutions we offer. In addition to an update on our latest customer projects, you will also find out more about our new Self-Service Portal, our offering for cell therapy manufacturer, and data integrity.
From Industry 4.0 to Pharma 4.0: ISPE Article of the Year
The current submission-based control strategy does not consider GMP, facilities, equipment and other production-specific controls to mitigate risk and ensure an effective, reliable production process. Transforming today’s control strategy to commercial manufacturing by technology transfer and scaling requires a best practice methodology that will change the current control strategy into a holistic production control strategy.
In their article, which received the ISPE 2017 Article of the Year award, the authors Christoph Herwig, Christian Wölbeling and Thomas Zimmer identify the need for a redefined control strategy implementation methodology.
Read more at Pharmaceutical Engineering
